Annual CFI
$60.78 M
+$6.75 M+12.49%
December 31, 2024
Summary
- As of February 24, 2025, BBIO annual cash flow from investing activities is $60.78 million, with the most recent change of +$6.75 million (+12.49%) on December 31, 2024.
- During the last 3 years, BBIO annual CFI has risen by +$261.61 million (+130.27%).
- BBIO annual CFI is now -86.59% below its all-time high of $453.15 million, reached on December 31, 2022.
Performance
BBIO Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$3.24 M
-$41.46 M-108.47%
December 31, 2024
Summary
- As of February 24, 2025, BBIO quarterly cash flow from investing activities is -$3.24 million, with the most recent change of -$41.46 million (-108.47%) on December 31, 2024.
- Over the past year, BBIO quarterly CFI has dropped by -$41.46 million (-108.47%).
- BBIO quarterly CFI is now -102.16% below its all-time high of $149.70 million, reached on June 30, 2022.
Performance
BBIO Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$60.78 M
-$3.17 M-4.96%
December 31, 2024
Summary
- As of February 24, 2025, BBIO TTM cash flow from investing activities is $60.78 million, with the most recent change of -$3.17 million (-4.96%) on December 31, 2024.
- Over the past year, BBIO TTM CFI has dropped by -$3.17 million (-4.96%).
- BBIO TTM CFI is now -86.70% below its all-time high of $456.98 million, reached on September 30, 2022.
Performance
BBIO TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
BBIO Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.5% | -108.5% | -5.0% |
| 3 y3 years | +130.3% | -108.5% | -5.0% |
| 5 y5 years | +128.0% | -108.5% | -5.0% |
BBIO Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -86.6% | +130.3% | -102.2% | at low | -86.7% | +130.3% |
| 5 y | 5-year | -86.6% | +128.0% | -102.2% | +98.8% | -86.7% | +116.3% |
| alltime | all time | -86.6% | +128.0% | -102.2% | +98.8% | -86.7% | +116.3% |
BridgeBio Pharma Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $60.78 M(+12.5%) | -$3.24 M(-108.5%) | $60.78 M(-5.0%) |
| Sep 2024 | - | $38.23 M(+1157.8%) | $63.95 M(+0.9%) |
| Jun 2024 | - | $3.04 M(-86.6%) | $63.41 M(-1.7%) |
| Mar 2024 | - | $22.75 M(<-9900.0%) | $64.49 M(+19.3%) |
| Dec 2023 | $54.03 M(-88.1%) | -$66.00 K(-100.2%) | $54.03 M(-25.0%) |
| Sep 2023 | - | $37.68 M(+814.8%) | $72.06 M(-60.2%) |
| Jun 2023 | - | $4.12 M(-66.5%) | $181.24 M(-44.5%) |
| Mar 2023 | - | $12.30 M(-31.5%) | $326.82 M(-27.9%) |
| Dec 2022 | $453.15 M(-325.6%) | $17.96 M(-87.8%) | $453.15 M(-0.8%) |
| Sep 2022 | - | $146.86 M(-1.9%) | $456.98 M(+23.8%) |
| Jun 2022 | - | $149.70 M(+8.0%) | $369.09 M(+67.9%) |
| Mar 2022 | - | $138.62 M(+535.9%) | $219.85 M(-209.5%) |
| Dec 2021 | -$200.83 M | $21.80 M(-63.0%) | -$200.83 M(+43.8%) |
| Sep 2021 | - | $58.97 M(>+9900.0%) | -$139.61 M(-42.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $458.00 K(-100.2%) | -$243.63 M(-34.7%) |
| Mar 2021 | - | -$282.05 M(-439.7%) | -$373.07 M(+604.0%) |
| Dec 2020 | -$52.99 M(-75.6%) | $83.02 M(-284.3%) | -$52.99 M(-65.3%) |
| Sep 2020 | - | -$45.05 M(-65.1%) | -$152.91 M(-49.9%) |
| Jun 2020 | - | -$128.98 M(-439.2%) | -$305.20 M(+72.6%) |
| Mar 2020 | - | $38.02 M(-325.0%) | -$176.80 M(-18.6%) |
| Dec 2019 | -$217.25 M(+932.8%) | -$16.90 M(-91.4%) | -$217.25 M(+6.5%) |
| Sep 2019 | - | -$197.34 M(>+9900.0%) | -$203.95 M(+2727.2%) |
| Jun 2019 | - | -$583.00 K(-76.0%) | -$7.21 M(-12.9%) |
| Mar 2019 | - | -$2.43 M(-32.6%) | -$8.29 M(-60.6%) |
| Dec 2018 | -$21.04 M(+4433.6%) | -$3.60 M(+494.9%) | -$21.04 M(+20.6%) |
| Sep 2018 | - | -$605.00 K(-63.4%) | -$17.44 M(+3.6%) |
| Jun 2018 | - | -$1.66 M(-89.1%) | -$16.83 M(+10.9%) |
| Mar 2018 | - | -$15.18 M | -$15.18 M |
| Dec 2017 | -$464.00 K | - | - |
FAQ
- What is BridgeBio Pharma annual cash flow from investing activities?
- What is the all time high annual CFI for BridgeBio Pharma?
- What is BridgeBio Pharma annual CFI year-on-year change?
- What is BridgeBio Pharma quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly CFI year-on-year change?
- What is BridgeBio Pharma TTM cash flow from investing activities?
- What is the all time high TTM CFI for BridgeBio Pharma?
- What is BridgeBio Pharma TTM CFI year-on-year change?
What is BridgeBio Pharma annual cash flow from investing activities?
The current annual CFI of BBIO is $60.78 M
What is the all time high annual CFI for BridgeBio Pharma?
BridgeBio Pharma all-time high annual cash flow from investing activities is $453.15 M
What is BridgeBio Pharma annual CFI year-on-year change?
Over the past year, BBIO annual cash flow from investing activities has changed by +$6.75 M (+12.49%)
What is BridgeBio Pharma quarterly cash flow from investing activities?
The current quarterly CFI of BBIO is -$3.24 M
What is the all time high quarterly CFI for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly cash flow from investing activities is $149.70 M
What is BridgeBio Pharma quarterly CFI year-on-year change?
Over the past year, BBIO quarterly cash flow from investing activities has changed by -$41.46 M (-108.47%)
What is BridgeBio Pharma TTM cash flow from investing activities?
The current TTM CFI of BBIO is $60.78 M
What is the all time high TTM CFI for BridgeBio Pharma?
BridgeBio Pharma all-time high TTM cash flow from investing activities is $456.98 M
What is BridgeBio Pharma TTM CFI year-on-year change?
Over the past year, BBIO TTM cash flow from investing activities has changed by -$3.17 M (-4.96%)